ANTIDIABETIC AND ANTIHYPERLIPIDEMIC EFFCETS OF THE ETHANOLIC EXTRACT OF ALOCASIA INDICA RHIZOMES IN HIGH FAT DIET/STREPTOZOTOCIN AND STREPTOZOTOCIN/NICOTINAMIDE-INDUCED TYPE 2 DIABETIC RATS

Authors

  • Talha Jawaid Department of Pharmacology, Hygia Institute of Pharmaceutical Education and Research, Ghaila Road, Lucknow, Uttar Pradesh - 226 020, IndiaARGAL
  • Saumya Argal Department of Pharmacology, Hygia Institute of Pharmaceutical Education and Research, Ghaila Road, Lucknow, Uttar Pradesh - 226 020, India
  • Mehnaz Kamal Faculty of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, Uttar Pradesh - 226 026, India

Abstract

Objective: The investigate the antidiabetic and antihyperlipidemic effect of ethanolic extract of Alocasia indica (EEAI) rhizomes in high-fat
diet/streptozotocin (HFD/STZ) and STZ/nicotinamide-induced Type 2 diabetic rats.
Methods: Diabetes was induced in male Wistar rats by the administration of a HFD for 15 days/STZ (35 mg/kg b.w., i.p.) and STZ (60 mg/kg b.w.,
i.p.)/nicotinamide (110 mg/kg b.w., i.p.). EEAI (100 and 200 mg/kg b.w., p.o.) was administered to diabetic rats for 28 days in HFD/STZ-induced
Type 2 diabetic rats and for 15 days in STZ/nicotinamide-induced Type 2 diabetic rats. The effect of EEAI on blood glucose and body weight was
studied in Type 2 diabetic rats. All these effects were compared with glibenclamide (5 mg/kg b.w., p.o.) as a reference antidiabetic drug.
Results: The administration of the EEAI (100 and 200 mg/kg b.w., p.o.) resulted in a significant decrease in blood glucose level and significant increase
in body weight in the HFD/STZ and STZ/nicotinamide-induced Type 2 diabetic rats. Further EEAI showed antihyperlipidemic activity as evidenced
by significant decrease in serum total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), very LDL-C levels coupled together with
elevation of high-density lipoprotein cholesterol level in diabetic rats in the HFD/STZ and STZ/nicotinamide-induced Type 2 diabetic rats.
Conclusion: The results suggest that the EEAI rhizomes possess a promising effect on the HFD/STZ and STZ/nicotinamide-induced Type 2 diabetes.
Keywords: Antidiabetic, Antihyperlipidemic, Alocasia indica, High-fat diet, Streptozotocin, Nicotinamide.

Downloads

Download data is not yet available.

Author Biographies

Talha Jawaid, Department of Pharmacology, Hygia Institute of Pharmaceutical Education and Research, Ghaila Road, Lucknow, Uttar Pradesh - 226 020, IndiaARGAL

Department of Pharmacology, Hygia Institute of Pharmaceutical Education and Research, Ghaila Road, Lucknow, Uttar Pradesh - 226 020, India

Saumya Argal, Department of Pharmacology, Hygia Institute of Pharmaceutical Education and Research, Ghaila Road, Lucknow, Uttar Pradesh - 226 020, India

Department of Pharmacology, Hygia Institute of Pharmaceutical Education and Research, Ghaila Road, Lucknow, Uttar Pradesh - 226 020,  India



Mehnaz Kamal, Faculty of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, Uttar Pradesh - 226 026, India

Faculty of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, Uttar Pradesh - 226 026, India

References

Christudas S, Savarimuthu I, Paul A. Antidiabetic effect of

Symplocos cochichinensis (Lour.) S. Moore in type 2 diabetic rats.

J Ethnopharmacol 2011;134(2):298-304.

Sharma V, Kumar S, Patel H. Hypoglycemic activity of Ficus Glomerata

in alloxan induced diabetic rats. Indian J Pharmacol 2010;1:18-22.

Treated group

(EEAI 100 mg/kg b.w.)

Treated group

(EEAI 200 mg/kg b.w.)

TC (mg/dl) 92.50±6.56 186.25±7.66 103.22±5.62 99.74±5.28 94.64±4.88

TG (mg/dl) 64.40±4.73 198.36±7.28 92.60±5.82 78.86±4.26** 72.27±4.16

HDL-C (mg/dl) 42.58±1.32 26.20±0.86 32.02±0.71* 36.84±1.16 40.28±1.76**

LDL-C (mg/dl) 37.04±1.22 120.38±6.76 52.68±4.75** 42.87±2.75 39.91±1.63**

VLDL-C (mg/dl) 12.88±0.94 39.67±1.45 18.52±1.16 15.77±0.85 14.45±0.83

Each value is mean±SEM of 6 rats in each group. *p<0.05, **p<0.01 and ***p<0.001 in comparison to diabetic control. EEAI: Ethanolic extract of Alocasia indica,

TG: Triglyceride, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol, VLDL-C: Very low-density lipoprotein cholesterol, High fat

diet, STZ: Streptozotocin, SEM: Standard error of mean

Table 7: Effect of EEAI on TC, TG, HDL-C, LDL-C and VLDL-C levels in STZ/nicotinamide-induced Type 2 diabetic rats

Lipid level Control Diabetic

control

Treated group

(EEAI 100 mg/kg b.w.)

Treated group

(EEAI 200 mg/kg b.w.)

TC (mg/dl) 71.60±5.68 166.20±6.66 97.20±5.73 94.47±5.68 83.64±4.68

TG (mg/dl) 74.40±5.89 176.60±6.87 102.60±6.87 91.82±5.66** 85.02±4.05

HDL-C (mg/dl) 25.60±1.53 10.20±0.66 15.02±0.71* 20.26±0.66 23.82±0.57**

LDL-C (mg/dl) 31.12±1.75 120.68±5.68 61.66±3.75** 55.85±0.87 42.82±0.83**

VLDL-C (mg/dl) 14.88±1.18 35.32±1.37 20.52±1.37 18.36±1.13 17.00±0.81

Each value is mean±SEM of 6 rats in each group. *p<0.05, **p<0.01 and ***p<0.001 in comparison to diabetic control. EEAI: Ethanolic extract of Alocasia indica,

TG: Triglyceride, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol, VLDL-C: Very low-density lipoprotein cholesterol, High fat

diet, STZ: Streptozotocin, SEM: Standard error of mean

Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination

of high-fat diet-fed and low-dose streptozotocin-treated rat: A model

for type 2 diabetes and pharmacological screening. Pharmacol Res

;52(4):313-20.

Larner J. The Pharmacological Basis of Therapeutics. 7

Standard

group

Standard

group

ed. New York:

Macmillan; 1985.

th

Bailey CJ, Day C. Traditional plant medicines as treatments for

diabetes. Diabetes Care 1989;12(8):553-64.

WHO Expert Committee on Diabetes Mellitus. Technical Reports

Series. Geneva: World Health Organization; 1980.

Gupta RK, Kesari AN, Murthy PS, Chandra R, Tandon V, Watal G.

Hypoglycemic and antidiabetic effect of ethanolic extract of leaves

of Annona squamosa L. in experimental animals. J Ethnopharmacol

;99(1):75-81.

Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, AguilarContreras

A,

Contreras-Weber

CC,

Flores-Saenz JL.

Study of

the antihyperglycemic

effect

of

plants used

as antidiabetics. J

Ethnopharmacol

;61(2):101-10.

Srinivasan K, Ramarao P. Animal models in type 2 diabetes research; an

overview. Indian J Med Res 2007;125(3):451-72.

Mulla WA, Salunkhe RV, Kuchekar VR. Free radical scavenging

activity of leaves of Alocasia indica. Indian J Pham Sci

;71(3):303-7.

Mulla WA, Salunkhe VR, Bhise SB. Hepatoprotective activity of

hydroalcoholic extract of leaves of Alocasia indica (Linn.). Indian J

Exp Biol 2009;47(10):816-21.

Mulla WA, Chopade AR, Bhise SB, Burade KB, Khanwelkar CC.

Evaluation of antidiarrheal and in vitro antiprotozoal activities of

extracts of leaves of Alocasia indica. Pharm Biol 2011;49(4):354-61.

Mulla WA, Vard ST, Rohan VP. Evaluation of anthelmintic activity of

leaves of Alocasia indica. Int J PharmTech Res 2010;2:26-30.

Mulla WA, Sargade PB, Parwar AM. Evaluation of antimicrobial activity

of leaves of Alocasia indica. Int J PharmTech Res 2010;2:327-33.

WHO. Quality Control Methods for Medicinal Plants Materials.

Geneva: World Health Organization; 1998. p. 32.

Trease GE, Evans WC. A Text Book of Pharmacognosy. Oxford: ELSB

Baillere Tindal; 1987. p. 1055.

Zhou J, Zhou S, Tang J, Zhang K, Guang L, Huang Y, et al. Protective

effect of berberine on beta cells in streptozotocin- and highcarbohydrate/high-fat

diet-induced

diabetic

rats.

Eur J Pharmacol

;606(1-3):262-8.

Kumar EK, Janardhana GR. Antidiabetic activity of alcoholic stem

extract of Nervilia plicata in streptozotocin-nicotinamide induced

type 2 diabetic rats. J Ethnopharmacol 2011;133(2):480-3.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the

concentration of low-density lipoprotein cholesterol in plasma, without

use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502.

Asian J Pharm Clin Res, Vol 8, Issue 6, 2015, 58-62

Jawaid et al.

Beppu H, Shimpo K, Chihara T, Kaneko T, Tamai I, Yamaji S, et al.

Antidiabetic effects of dietary administration of Aloe arborescens Miller

components on multiple low-dose streptozotocin-induced diabetes in

mice: Investigation on hypoglycemic action and systemic absorption

dynamics of aloe components. J Ethnopharmacol 2006;103(3):468-77.

Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the

pharmacology of endocrine pancreas. In: Hardman JG, Limberd LE,

Malinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman’s

the Pharmacological Basis of Therapeutics. 9

ed. New York:

Published

01-11-2015

How to Cite

Jawaid, T., S. Argal, and M. Kamal. “ANTIDIABETIC AND ANTIHYPERLIPIDEMIC EFFCETS OF THE ETHANOLIC EXTRACT OF ALOCASIA INDICA RHIZOMES IN HIGH FAT DIET/STREPTOZOTOCIN AND STREPTOZOTOCIN/NICOTINAMIDE-INDUCED TYPE 2 DIABETIC RATS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 8, no. 6, Nov. 2015, pp. 58-62, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/7084.

Issue

Section

Original Article(s)